Impact Cryotherapy Formed to Meet Growing Demand for U.S.-Made Whole Body Cryotherapy Systems

Impact Cryotherapy has been launched in response to increasing requests for a whole body cryotherapy system designed and manufactured in the United States. The company, formed by veteran healthcare executives, is already filling orders for the systems from customers, including sports teams, physical therapy facilities, health clubs, retail locations, trainers and individuals.

Cryotherapy is used worldwide by athletes and others to maintain fitness and increase energy. Athletes, ranging from professionals to weekend warriors, claim that whole body cryotherapy gives them an edge over competitors by allowing them to recover faster from workouts and train harder. Other advocates of cryotherapy seek total body wellness or relief from inflammation.

“Whole body cryotherapy has a growing base of fans who believe strongly in its benefits,” says Richard E. Otto, Chief Executive Officer and Co-Founder of Impact Cryotherapy. “We saw that cryotherapy has growing adoption, but all systems were made overseas. It became apparent to us that there was an enormous demand for an American-designed and American-manufactured system.”

“We are pleased to have our corporate headquarters in Atlanta, where manufacturing of the systems is also taking place. We have already sold the cryotherapy systems to customers across the country. We also plan to open an Impact Cryotherapy retail facility during the next six months, which will augment our direct sales of equipment and allow more individuals to benefit from the advantages of cryotherapy,” Otto added.

Extreme cold has been used to treat inflammation for centuries, but modern applications began during the 1970s in Japan, where cryotherapy treatments were used to treat rheumatoid arthritis. Since then, numerous clinical studies have been conducted in Europe, which developed the whole body cryotherapy systems in use today.

The user stands inside the patent-pending, octagonal-shaped chamber during treatment on an adjustable platform, which ensures their head remains outside the chamber. The Impact Cryotherapy chamber is filled with nitrogen vapor, which drops the temperature to a range of (minus) -​140°C to -170°C and temporarily lowers the temperature of the skin’s top layer. This treatment lasts a maximum of three minutes. During the process, the skin sends signals to the brain, which stimulates physical reactions and activates naturally occurring healing resources. Once out of the chamber, the body immediately reheats.

“The American-made Impact Cryotherapy whole body system represents the most advanced approach to the proven treatment of cold therapy and is clearly distinguishable from foreign-made units,” says Robert T. Atwood, Chief Operating Officer and Co-Founder.  “Additionally, the system offers an attractive return on investment because of its cost effectiveness and the rapid throughput, thanks to the very nature of cryotherapy treatments. The compact footprint makes it suitable for a variety of settings.”

About Impact Cryotherapy
Impact Cryotherapy is the national leader in designing and manufacturing whole body cryotherapy systems. The company’s state-of-the-art systems are sleek, attractive single-person chambers that are engineered and manufactured in the United States in an ISO 9001 and ISO 14001 certified facility. Impact Cryotherapy is redefining the age-old technique of cryotherapy with advanced technology and aesthetics to deliver unmatched efficiency, comfort and reliability.

PatientFocus Enters into Agreement with Medical Supply Company Verus Healthcare

High-growth medical billing company PatientFocus announced today that it has entered into an agreement with Verus Healthcare. Through the terms of the agreement, PatientFocus will provide Verus its full range of billing services allowing patients access to flexible, interest-free payment options without a credit check.

Verus Healthcare, formerly known as CPAP Care Club, is a healthcare supply company located in Franklin, Tenn., specializing in respiratory, urological and other medical supplies. Serving over forty thousand patients across the country, the company has won competitive bid contracts in all 50 states for its products and has managed care contracts covering over 200 million patients in the U.S.  Verus has grown its patient base seven-fold over the last two years while maintaining a 99.2% patient satisfaction rating.

“Verus is committed to providing the highest level of service and customer satisfaction to our patients,” said Verus President Emmet Seibels. “Our partnership with a company like PatientFocus, who shares our vision, is evidence of that commitment.”

PatientFocus is a fast growing and innovative medical billing company focused exclusively on patient-pay collections after insurance and before bad debt. The company functions as an extension of a client’s billing office, managing 100 percent of patient communications, including statements, inbound and outbound telephone follow-up and online payment options.

“It is a tremendous honor for PatientFocus to be able to provide our services to an industry leader such as Verus,” said CEO and Founder David Frederiksen. “Our company is committed to providing the highest quality service to make the billing process easier and more effective for Verus and its patients.”

About Verus Healthcare
Verus Healthcare, Inc. is a health care supply company located in Franklin, Tenn. specializing in respiratory, urological and other medical supplies.  The company provides direct to patient services to tens of thousands of patients throughout the U.S. for their medical supplies through its national call center.  Verus Healthcare is one of a very select group of companies to win Medicare competitive bid contracts in all 50 states for its products, and the company has managed care contracts covering all 50 states and over 200 million patients in the United States.

About PatientFocus
PatientFocus, Inc., based in Nashville, Tenn., is a medical billing company focused exclusively on self-pay and patient-pay accounts after insurance and before bad debt collections. The company functions as an outsourced extension of its clients’ billing offices, providing every patient flexible, interest-free payment options without a credit check. PatientFocus manages 100 percent of patient communications, including statements, inbound and outbound telephone follow-up and online payment options. Online: www.patientfocus.com

RegionalCare Hospital Partners Selects Agilum to Provide Business Intelligence Solutions

Agilum Healthcare Intelligence announced today that its healthcare business intelligence (BI) solutions and services will be used by RegionalCare Hospital Partners Inc., a leading owner and operator of regionally focused community hospitals in non-urban markets across the United States, to provide healthcare business intelligence (BI) solutions and services.

“The ability to easily access business intelligence that is both hospital-specific and company-wide will benefit all of our hospitals, and ultimately, every patient that we serve,” said Alan Wenk, VP of Financial Operations, RegionalCare Hospital Partners.

Agilum’s business intelligence solutions, specifically designed to meet the needs of hospitals and healthcare systems, transform millions of data points from multiple source systems into actionable business analytics. Agilum customers rely on this real-time information to improve performance, profitability and quality.

“We are very pleased to have been selected by RegionalCare to provide unique, valuable insights generated by our business intelligence solutions,” said Roy Mathews, Founder and President, Agilum Healthcare Intelligence. “Agilum’s ability to pull information from a range of disparate technology systems and integrate it into a unified view offers deep value for operations, financial performance and patient care.”

Agilum offers unique advantages to healthcare systems with its easy-to-implement, cloud-based solutions that provide deep Oracle functionality at an affordable monthly subscription fee. Hospitals immediately begin receiving new insights that assist with making informed, timely decisions.

About RegionalCare Hospital Partners
RegionalCare Hospital Partners is a growing system of community hospitals focused on a commitment to high quality care and expanding health care services in non-urban markets. Today, RegionalCare is partnered with eight, market-leading, community hospitals in seven states. More information can be found at www.regionalcare.net.

About Agilum Healthcare Intelligence
Agilum Healthcare Intelligence provides business intelligence (BI) solutions and services that are specifically designed to meet the needs of hospitals and healthcare systems. Leveraging a software-as-a-service (SaaS) model, Agilum provides its US and international hospital clients customers with the ability to quickly and affordably transform huge volumes of financial and operational data, drawn from multiple source systems, into clear, actionable business intelligence improving performance, profitability and quality.

Agilum Offers Business Intelligence to Broader Healthcare Market with New Website and Products

With a newly revamped website and an arsenal of innovative business intelligence solutions for healthcare providers, Agilum Healthcare Intelligence has positioned itself as a go-to provider of business intelligence (BI) solutions in a rapidly evolving healthcare landscape.

The continued implementation of regulations surrounding the Affordable Care Act have greatly increased data demands on healthcare providers, along with the need for powerful business tools to manage them. Smoothing this transition is Agilum with its suite of affordable, turnkey business intelligence solutions designed for health systems and hospitals of all sizes.

“Our solutions are designed with the goal of bringing the right information to the right people at the right time,” said Roy Mathews, Agilum Founder and President. “Operational questions that used to take days or weeks to answer are now analyzed with the click of a button using Agilum’s technology.”

“In the past, huge labor and implementation costs meant that only the largest hospitals and health systems could afford business intelligence solutions of the kind Agilum provides. By leveraging the SaaS delivery model, we are able to bring these capabilities to the broader healthcare marketplace,” said Mathews.

Agilum’s cost-effective, Oracle-based solutions include:

  • Service Line Costing & Profitability
    Enables customers to realize cost and utilization improvement, service line profitability, volume-building opportunities and identify optimal capital budget investment initiatives
  • Productivity Management
    Monitors staffing levels and trends allowing customers to quickly adapt to patient volume changes and manage salary expenses without sacrificing quality of car
  • Physician Data
    Measures and monitors physician productivity and compares against national benchmarks, as well as automates physician compensation calculations
  • Revenue Cycle Performance
    Streamlines revenue cycle management and monitors A/R performance indicators and net revenue modeling at the patient level
  • Operational Performance
    Captures, tracks and analyzes healthcare-specific key performance indicators for operating volume, finance, efficiency and more
  • Ad Hoc Reporting & Excel Add-in
    Facilitates complete querying capabilities for companies to leverage Agilum’s data warehouse, gaining more in-depth intelligence

Offered through a software-as-a-service (SaaS) model, Agilum’s solutions require no upfront capital expenditure and can be fully implemented within 90 days in facilities ranging from large-scale hospitals to mid-size providers. Taking what were once costly, capital-intensive data mining processes for customers’ finance and operations staff, Agilum’s solutions deftly digest and package data into insightful reports, dashboards and forecasts, drastically reducing the headache of producing analytics.

Based in the healthcare services capitol of Nashville, Tenn., and founded by healthcare services and technology veterans, Agilum boasts a highly skilled team that is dedicated to providing business intelligence solutions, improving performance, profitability and quality for its clients.

About Agilum Healthcare Intelligence
Agilum Healthcare Intelligence provides business intelligence (BI) solutions and services that are specifically designed to meet the needs of hospitals and healthcare systems. Leveraging a software-as-a-service (SaaS) model, Agilum provides its US and international hospital clients with the ability to quickly and affordably transform huge volumes of financial and operational data, drawn from multiple source systems, into clear, actionable business intelligence improving performance, profitability and quality.

DiaTech Oncology to Invest $2.7 Million to Expand Franklin, TN Operations Creating 39 New Jobs

Tennessee Economic and Community Development Commissioner Bill Hagerty along with DiaTech Oncology officials announced today the company will expand operations in Franklin, Tenn. DiaTech’s investment of $2.7 million will create 39 new positions over the next two years in Williamson County.

“Tennessee is a top state when it comes to research and development expenditures, and we are focused on leveraging our remarkable R&D assets, along with our strengths in the health care industry, to attract innovative companies like DiaTech to locate and expand in our state,” Hagerty said. “I appreciate DiaTech for their investment in Williamson County that will not only benefit our citizens and economy, but cancer patients and physicians worldwide.”

“DiaTech is pleased to begin its first U.S. laboratory operation in Franklin, Tennessee,” DiaTech Oncology President Garry Latimer said. “This laboratory is under development with a planned opening of its specialized ‘Correct Chemo Assay’ cancer testing facility in early 2014.”

“DiaTech’s test is the only test on the market that reveals to the treating oncologist the most effective chemotherapy for inducing cell death in the malignant cells of a particular cancer patient. As our clinical studies show, DiaTech’s test can guide therapy in individual patients,” DiaTech Oncology Chief Medical Officer Cary Presant, M.D., said.

Offering patient-specific chemotherapy testing, DiaTech helps oncologists determine the best cancer treatment plans for their patients. The company uses a patented technology called Microculture Kinetic (MiCK) assay which measures cell death induced in a specific patient’s cancer cells by chemotherapy. The analysis, which has been used successfully in more than 50 different tumor types, is the only test on the market that evaluates the chemotherapeutic drug effect for a specific patient and can tell which chemotherapy drugs are most effective.

“I am thrilled DiaTech has selected Williamson County as the location for their first U.S. lab operation in the United States,” Williamson County Mayor Rogers Anderson said. “Williamson County has been focused on developing the life sciences sector for years, and DiaTech’s investment in our community is a direct result of hard work by a number of community leaders.”

“Health care is one of the foundational economic sectors in Williamson County,” Williamson County Chamber of Commerce President and CEO Matt Largen said. “DiaTech’s laboratory operation will help us diversify the health care sector by capturing the increasingly important research and development component. I am thankful DiaTech selected Williamson County and look forward to partnering with them to grow their presence here.”

The 39 new jobs include technical staffing positions for medical technologists with extensive experience in isolation, purification and culturing of tumor cells from human tissues, diagnostic multiparameter flow cytometry, and histology and immunohistochemistry. To apply, please forward your resume to career@diatech-oncology.com.

About DiaTech Oncology
DiaTech Oncology, based in Nashville, Tenn., is a life sciences and clinical pathology laboratory company that offers patient-specific chemotherapy testing to help oncologists determine the best cancer treatment plans for their patients. DiaTech utilizes a patented technology called the Microculture Kinetic (MiCK) assay, which measures apoptosis (cell death) induced in a specific patient’s cancer cells by chemotherapy. The only test on the market that evaluates the chemotherapeutic drug effect for a specific patient and can tell which chemotherapy drugs are most effective, the MiCK assay has successfully tested all types of cancer. The MiCK assay is also used to determine the effectiveness of new drugs in preclinical trials for the pharmaceutical industry. Visit us at www.diatech-oncology.com.

nTelagent Inc. Becomes RevPoint Healthcare Technologies

Revenue cycle management company nTelagent, Inc., based in Nashville, has changed its name to RevPoint Healthcare Technologies, officials announced today.

Since 2005, RevPoint has provided hospitals and clinics across the country with an advanced revenue cycle management solution that helps healthcare providers and their patients navigate a complex reimbursement environment, focusing on enhancing collections at the point of service. With an average return on investment of 3:1, RevPoint’s SmartCycle™ technology also leads to a better patient experience and increased employee performance and satisfaction.

“Our new name says a lot about us,” said Hal Andrews, Chairman, President and Chief Executive Officer. “We serve clients by partnering with them and pointing them in the right direction to increase revenue.”

Andrews says hospitals are increasingly focused on managing the “patient portion” of the revenue cycle, especially in the face of uncertainty related to health insurance exchanges that are scheduled to begin enrolling individuals on Oct. 1, 2013.

“Our name is changing, but our mission is not,” Andrews said. “We remain dedicated to helping providers thrive financially and better care for patients in this quickly evolving healthcare environment.”

By guiding employees through each patient encounter in real time, SmartCycle™ leads to fast, simple and accurate account resolution for all patients at the point of service, whether patients are insured, uninsured, underinsured and/or qualify for financial assistance.

“Our product is a proven solution and an invaluable tool for healthcare providers today,” said Chief Product Strategy Officer Irene Barron. “It simplifies the payment process, increases revenue collections and makes patients and employees happier. At the end of the day, it helps our clients succeed.”

To learn more about RevPoint visit www.revpointhealth.com.

About RevPoint Healthcare Technologies
RevPoint is a revenue cycle management company with a proven solution to increase point-ofservice collections, enhance employee performance and improve patient satisfaction. Our technology leads to fast, simple and accurate resolution of all patient accounts at the point of service, whether patients are insured, uninsured, underinsured and/or qualify for financial assistance. We are the leading solution for healthcare providers in need of a valuable partner at the front end of the revenue cycle.

REACH Health Named to Inc. Magazine Fastest-Growing Companies List

REACH Health, the leading provider of telemedicine software solutions, has been recognized by Inc. magazine in the 2013 Inc. 5000, an exclusive ranking of the nation’s fastest-growing private companies.

The Inc. 500|5000 ranks companies by overall revenue growth over a three-year period. REACH Health has had tremendous growth, more than doubling revenues between 2009 and 2012.

“For 32 years, Inc. has welcomed the fastest-growing private companies in America into a very exclusive club,” said Eric Schurenberg, Editor in Chief, Inc. magazine. “Make no mistake: The Inc. 5000 was harder to get into this year than ever in its history.”

“We are very pleased to be recognized by Inc.,” said Richard Otto, President and CEO of REACH Health. “Our growth is attributable to two factors:  First, we have a terrific team at REACH Health that works very hard to ensure the high level of clinical relevance, system reliability and customer satisfaction. Second, telemedicine is being recognized as a critical software technology in helping healthcare organizations deliver timely, quality care to their patients in a cost-effective manner.”

About REACH Health
REACH Health technology powers many of the nation’s largest, fastest growing and most successful telemedicine networks, helping health systems and accountable care organizations achieve measurable improvements in their clinical, operational and financial performance. REACH Health best-in-class software solutions combine real-time audio/video technology with vital patient data, clinical workflow and documentation to overcome the traditional obstacles of time and distance. By securely connecting physicians anytime, anywhere, REACH Health technology enables remote consultations, connects patients with specialists, and supports collaboration by clinical care teams. Physicians and clinicians embrace the ease of use of a single, intuitive platform tailored to multiple specialties. REACH Health pioneered one of the nation’s first telestroke programs and remains the innovation leader, providing the most advanced clinical solutions to improve population health and address today’s demanding healthcare mandates. For more information, visit www.reachhealth.com.

PatientFocus Signs Agreement with Choice Medical

PatientFocus, a medical billing company providing enhanced patient billing services, today announced an agreement with Choice Medical, Inc., a specialty distributor of orthopedic, neurosurgical, orthotic and prosthetic product lines. The agreement will give Choice Medical patients access to Patient Focus’ suite of patient-pay account management services.

Since its 2002 launch, Choice Medical has experienced tremendous growth in orthopedic and spinal instrumentation fixation products, durable medical equipment and sports medicine bracing. The Knoxville, Tenn.-based company represents more than 80 manufacturers in 10 states with more than 100 combined accounts including hospitals, physician offices and surgery centers.

PatientFocus, based in Nashville, Tenn., focuses exclusively on patient-pay collections after insurance and before bad debt. PatientFocus functions as an extension of a billing office, providing patients with flexible, interest-free payment options without a credit check. PatientFocus manages 100 percent of patient communications, including statements, inbound and outbound telephone follow-up and online payment options.

“We’re impressed with Patient Focus’ emphasis on customer satisfaction during the billing process,” said Jennifer Monroe, Director of Billing Services of Choice Medical. “As a company, we are dedicated to successful patient communication to provide the best possible service to patients, physicians and hospitals. We’re excited to offer access to PatientFocus’ knowledgeable patient services team along with payment options that are convenient and flexible.”

PatientFocus will provide ChoiceMedical’s patients access to its financial counselors and allow patients to select payment plans online via their smartphone or computer. They can pay over time, interest-free, in a variety of ways, including check, credit card, bank draft, Health Savings Account and PayPal.

“Choice Medical is a dynamic company serving thousands of patients who require medical products associated with orthopedic, prosthetic and neurosurgical needs,” said David E. Frederiksen, PatientFocus founder and CEO. “We’re excited about working with Choice Medical because we share the same values: integrity, transparency and customer satisfaction. We look forward to helping create a patient billing process that is a positive, win-win proposition for all parties involved.”

About Choice Medical
Choice Medical, Inc., based in Knoxville, Tenn., is a specialty distributor in the orthopedic, neurosurgical, orthotic and prosthetic market. Since its 2002 launch, Choice Medical has experienced tremendous growth in orthopedic and spinal instrumentation fixation products, durable medical equipment and third-party billing programs, and spinal and sports medicine bracing. The company represents more than 80 manufacturers in 10 states with over 100 combined accounts including hospitals, physician offices and surgery centers. Choice Medical is accredited by the Accreditation Commission for Health Care. Online: http://www.choicemedinc.com

About PatientFocus
PatientFocus, Inc., based in Nashville, Tenn., is a medical billing company focused exclusively on self-pay and patient-pay accounts after insurance and before bad debt collections. PatientFocus functions as an outsourced extension of its clients’ billing offices, providing every patient flexible, interest-free payment options without a credit check. PatientFocus manages 100 percent of patient communications, including statements, inbound and outbound telephone follow-up and online payment options. PatientFocus is experiencing rapid growth and has more than tripled clients in the past year. Clients include many leading national healthcare corporations, such as Anesthesia Medical Group, e+CancerCare and Optimal Radiology. Online: www.patientfocus.com

REACH Health Secures $7.4 Million in Funding

REACH Health, Inc., the leading provider of telemedicine software solutions, announced today that it has secured $7.4 million in funding. The investment firms of Buckhead Investment Partners, Council Capital and C&B Capital participated in a $4.4 million equity financing. In addition, REACH Health secured up to an additional $3 million in debt from Silicon Valley Bank.

The funding from these nationally recognized healthcare investors will enable REACH to maximize growth opportunities as more health systems implement REACH’s comprehensive telemedicine solutions to improve outcomes and reduce costs. The capital will also support the company’s continued rollout of the REACH Access platform for specialties such as neurology, cardiology, pulmonology, psychiatry and stroke.

Clinically driven REACH Health telemedicine solutions integrate real-time audio/video technology with vital patient information, images, workflow and documentation. The company’s multidiscipline workflows meet the needs of a wide range of specialties while allowing healthcare systems to invest in a single technology platform.

“We are pleased to complete this round of funding and believe that the commitment of our financial partners further validates the significant growth opportunities ahead for REACH Health,” said Richard Otto, President and CEO of REACH Health. “Telemedicine is playing an increasingly important role for healthcare systems, hospitals and accountable care organizations that need to deliver timely, quality care to their patients in a cost-effective manner.”

REACH Health was a pioneer of telestroke, and today remains at the forefront of the industry, with technology solutions that help health systems achieve measurable improvements in their clinical, operational and financial performance. By providing better access to physicians and specialists – regardless of location or time – health systems can increase patient satisfaction and quality of life while significantly impacting outcomes.

About REACH Health
REACH Health technology powers many of the nation’s largest, fastest growing and most successful telemedicine networks, helping health systems and accountable care organizations achieve measurable improvements in their clinical, operational and financial performance. REACH Health best-in-class software solutions combine real-time audio/video technology with vital patient data, clinical workflow and documentation to overcome the traditional obstacles of time and distance. By securely connecting physicians anytime, anywhere, REACH Health technology enables remote consultations, connects patients with specialists, and supports collaboration by clinical care teams. Physicians and clinicians embrace the ease of use of a single, intuitive platform tailored to multiple specialties. REACH Health pioneered one of the nation’s first telestroke programs and remains the innovation leader, providing the most advanced clinical solutions to improve population health and address today’s demanding healthcare mandates. For more information, visit www.reachhealth.com.

DiaTech Oncology Receives New York State Clinical Laboratory Permit

DiaTech Oncology, a life sciences and clinical pathology laboratory company based in Nashville, Tenn., today announced that the company has received a Clinical Laboratory Permit from the New York State Department of Health (NYS DOH). DiaTech’s  predictive assay test — which  guides the treating oncologist to the most effective chemotherapy for inducing cell death in the malignant cells of a particular cancer patient — is  now available to patients and physicians in all 50 states.

In clinical trials and published research, use of DiaTech Oncology’s test — the MiCK® assay or Correct Chemo® — has consistently shown an increase in complete or partial response rates, longer time to relapse and a trend to longer survival times for more than 50 types of cancers, including lung, breast, colorectal, stomach, prostate, liver, ovarian, esophageal, bladder, non-Hodgkin lymphoma, leukemia and other cancers.
“New York State has the most stringent requirements for laboratory test approval in the United States,” says Garry Latimer, DiaTech CEO. “Receiving this permit is great news for cancer patients. It affirms that our CAP-accredited, CLIA-certified laboratory meets the highest standards for accurate and reliable clinical laboratory services.”
”DiaTech’s predictive assay — the only test on the market that guides the treating oncologist to the most effective chemotherapy for inducing apoptotic cell death in the malignant cells of a particular cancer patient — is now available to more cancer patients and oncologists than ever before,” states Dr. Cary Presant, DiaTech Chief Medical Officer. “Our clinical studies consistently reveal that patients treated with MiCK assay-guided chemotherapy demonstrate longer survival times and lower costs, and our studies are continuing to produce unexpected new leads for innovative therapeutic strategies.”
DiaTech’s patented MiCK assay measures apoptosis, or cell death, in the cancer cells of chemotherapy patients. Tumor cells are exposed to multiple doses of several chemotherapeutic drugs, either as single drugs or combinations. An algorithm monitors and computes the amount of cell death and determines a drug sensitivity “score” of the patients’ tumor cells.
 
About DiaTech Oncology
DiaTech Oncology, based in Nashville, Tenn., is a life sciences and clinical pathology laboratory company that offers patient-specific chemotherapy testing to help oncologists determine the best cancer treatment plans for their patients. DiaTech utilizes a patented technology called the Microculture Kinetic (MiCK) assay, which measures apoptosis (cell death) induced in a specific patient’s cancer cells by chemotherapy. The only test on the market that evaluates the chemotherapeutic drug effect for a specific patient and can tell which chemotherapy drugs are most effective, the MiCK assay has successfully tested all types of cancer. The MiCK assay is also used to determine the effectiveness of new drugs in preclinical trials for the pharmaceutical industry. Online: www.diatech-oncology.com